Multispecifics and T cell engagers at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

34 organizations at PepTalk 2027 present work in multispecifics and t cell engagers: 23 drug developers, 7 suppliers and service providers and 4 academic, government and non-profit bodies. Between them they bring 74 presentations to the program. Most represented: AstraZeneca (10 on the program), Sanofi (5 on the program), Eli Lilly (5 on the program). As of Oct 17, 2026.

All 166 organizations at PepTalk 2027 →

Showing 1–8 of 34 organizations

Organization	PepTalk 2027 Attendance
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global pharmaceutical company developing antibodies, multispecifics and antibody-drug conjugates across oncology, respiratory, immunology and rare diseases.	Chair Mon Jan 18 8:50am–9:00am Chairperson's Remarks SYMPOSIUM: Predictive Protein Production Talk Mon Jan 18 9:30am–10:00am In silico Developability Assessment of Single- and Dual-Chain Antibodies SYMPOSIUM: Display of Biologics Talk Mon Jan 18 11:45am–12:15pm Predictive Assembly and Purification Schema for Multispecific Biologics Using Integrated AI/ML and Experimental QC Workflows SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 11:20am–11:50am Modular Generation of Multispecific Antibodies Using Protein Trans-Splicing Multispecifics Engineering & Design Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, Xencor, Eli Lilly +2 more Chair Tue Jan 19 1:25pm–1:30pm Chairperson's Remarks Recombinant Protein Production - Part 1 Talk Wed Jan 20 11:10am–11:40am Lipidic Platforms for Delivery of Complex Membrane Proteins in Lead Generation Recombinant Protein Production - Part 1 Talk Wed Jan 20 2:30pm–3:00pm End-to-End Automation of Intact Mass Spectrometry QC for Integrated Purification and Quality Workflows in High-Throughput Biologics Production Tools for Purification and Quality Talk Thu Jan 21 9:10am–9:40am Fit-for-Purpose Antibody Purification: A Strategic Guide to Scale, Selection, and Automation Readiness Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm Improving Dual Targeting Selectivity in T Cell Engagers via Synapse-Gated and Affinity-Tuned Trispecific Antibody Design Emerging T Cell Engagers Talk Thu Jan 21 1:40pm–2:00pm Scaling the Start: High-Throughput Generation of Transfection-Ready DNA and Scalable Workflows for Rapid Antibody Production Recombinant Protein Production - Part 2 / Tools for Purification and Quality Talk Thu Jan 21 2:40pm–3:10pm Rational Antibody Engineering for Multiparameter Developability Enhancement Biophysical Methods and Models Panel Thu Jan 21 3:00pm–3:40pm Building Effective Cross-Functional Protein Production Teams Recombinant Protein Production - Part 2 / Tools for Purification and Quality · with Thomson Instrument Company, UCLA, BioMarin +1 more
Sanofi Paris, France
sanofi.com Large pharma French pharmaceutical company with marketed medicines and vaccines, and biologics research that includes nanobody, multispecific and AI-based protein design.	Talk Mon Jan 18 1:35pm–2:05pm Two Cell Lines, One Goal: Enabling Reliable Cell-Based Assay Critical Reagent Production SYMPOSIUM: (Re) Discovering Protein Expression Platforms Talk Tue Jan 19 1:30pm–2:00pm AI-Driven Design of Mono- and Multispecific VHH Therapeutics Multispecifics Engineering & Design Talk Wed Jan 20 8:35am–9:05am Membrane Protein Expression and Production in Pharma R&D Pipelines Recombinant Protein Production - Part 1 Talk Wed Jan 20 3:30pm–4:00pm Strategic Non-Optimal Codon Usage Reduces Bispecific Protein Mispairing Recombinant Protein Production - Part 2 Chair Thu Jan 21 1:35pm–1:40pm Chairperson's Remarks Biophysical Methods and Models Talk Thu Jan 21 1:40pm–2:10pm High-Throughput Cryo Electron Microscopy and Machine Learning for Biologics Engineering: From Pipeline to Decisions Biophysical Methods and Models
Eli Lilly Indianapolis, IN
lilly.com Large pharma Global pharmaceutical company with peptide, antibody and other medicines in diabetes, obesity, oncology, immunology and neuroscience.	Talk Tue Jan 19 11:50am–12:20pm From Data Silos to Shared Insights: Democratizing Data and AI for Accelerated Biotherapeutics Analytics and Decision Making Analytical Intelligence Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more Panel Tue Jan 19 4:55pm–5:25pm AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard Plenary · with Novo Nordisk, Prescient Design, Generate Biomedicines Predictive and AI-driven protein science Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Plenary · with EPOC Scientific, Unnatural Products, Novo Nordisk +2 more Peptide discovery and developmentPredictive and AI-driven protein science Talk Wed Jan 20 5:40pm–6:10pm Predictive Accelerated Stability Studies: A Strategic Approach to Developing Oligonucleotide Therapeutics Biophysical Methods and Models
Gilead Sciences Foster City, CA
gilead.com Large pharma Biopharmaceutical company with medicines for HIV, liver disease, cancer and inflammation, and research on antibodies and multispecifics.	Talk Tue Jan 19 9:10am–9:40am Beyond the Binders: A Structure-Based Framework to Guide Engineering of Multispecific Antibodies across Formats Multispecifics Engineering & Design Chair Tue Jan 19 1:25pm–1:30pm Chairperson's Remarks Multispecifics Engineering & Design Talk Wed Jan 20 5:10pm–5:40pm Development of a PRAME pMHC Targeted T Cell Engager for Solid Tumor Therapy Emerging T Cell Engagers Chair Thu Jan 21 8:35am–8:40am Chairperson's Remarks Tools for Purification and Quality Talk Thu Jan 21 8:40am–9:10am Predicting CIEX Binding Behavior of Antibody Building Blocks to Enable High-Throughput Purification of Multispecifics Tools for Purification and Quality Talk Thu Jan 21 9:40am–10:10am Integrating Sequence, Structure, and Biophysical Data for Early Biologics Developability Prediction Biophysical Methods and Models
Regeneron Tarrytown, NY
regeneron.com Large pharma US biotechnology company with marketed antibody medicines, built on its VelocImmune humanized-mouse platform and in-house bispecific antibody engineering.	Talk Tue Jan 19 8:40am–9:10am AI-Powered Predictive Spectral Libraries for High-Confidence Sequence Variant Analysis in Therapeutic Antibodies Analytical Intelligence Talk Tue Jan 19 9:10am–9:40am Protein Expression and G Protein-Based Functional Characterization of Orphan GPCRs Recombinant Protein Production - Part 1 Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more Talk Thu Jan 21 3:10pm–3:40pm A Streamlined Workflow Enabling Efficient Preclinical Development of Novel Protein Therapeutics through Risk Assessment and Enhanced Communication Bridging Research and CMC Biophysical Methods and Models
Cytiva Marlborough, MA	◆Premier Sponsor
cytivalifesciences.com Instruments & analyticsPremier Sponsor Danaher company supplying chromatography systems and resins, Biacore binding analysis, filtration and cell culture products for biologics research and manufacturing.	Booth Exhibiting at Booth 507 Talk Tue Jan 19 10:10am–10:40am Talk Title to be Announced Multispecifics Engineering & Design Talk Tue Jan 19 12:25pm–12:55pm Talk Title to be Announced Automation in Protein Discovery Talk Wed Jan 20 4:00pm–4:30pm Talk Title to be Announced Tools for Purification and Quality
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company making medicines and vaccines, with in-house biologics discovery, protein engineering and protein production groups.	Talk Mon Jan 18 11:15am–11:45am Miniaturized Site-Specific Platform for Rapid Manufacturability Assessment of Biologic Candidates SYMPOSIUM: Predictive Protein Production Talk Wed Jan 20 8:35am–9:05am Engineering a p40/TL1A Bispecific Antibody for IBD: How Format Optimization Enabled Clinical Candidate Selection Multispecifics Engineering & Design Talk Wed Jan 20 11:40am–12:10pm Developing GPCR Production Workflows to Support DNA-Encoded Library Screening Recombinant Protein Production - Part 1
Zymeworks
zymeworks.com Biotech Clinical-stage biotech developing multispecific antibodies, antibody-drug conjugates and engineered cytokines; created the Azymetric bispecific platform.	Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more Chair Wed Jan 20 2:25pm–2:30pm Chairperson's Opening Remarks Emerging T Cell Engagers Talk Thu Jan 21 3:10pm–3:40pm Engineering IL-7 to Enhance Anti-Tumor Activity and Cytokine Delivery to the Tumor Microenvironment Emerging T Cell Engagers